GlobalUnited StatesUnited KingdomGermanyFranceIndiaJapanBrazil
More regions
CountriesCanadaMexicoItalySpainIrelandNetherlandsSwitzerlandAustraliaChinaSouth KoreaSingapore
RegionsAmericasLatin AmericaEuropeNordicsAsia-Pacific
Saturday 17 October 2026
M&A NEWS
Deal tracker

Top healthcare mergers and acquisitions of 2026

Every verified merger and acquisition in the healthcare sector in this period, ranked by disclosed value. Updated every morning.

We tracked 124 deals in the healthcare sector in 2026, 99 of them with a disclosed value, worth $224.2bn in total. The largest was Boston Scientific Corporation's $14.5bn deal for Penumbra, Inc., ahead of Sun Pharmaceutical Industries Ltd and Organon & Co. at $11.8bn.

Top healthcare mergers and acquisitions of 2026

All healthcare M&A deals →
  1. 115 JanBoston Scientific Corporation → Penumbra, Inc.Boston Scientific agrees US$14.5bn deal for PenumbraHealthcare / Medical devicesIn review$14.5bn
  2. 226 AprSun Pharmaceutical Industries Ltd → Organon & Co.Sun Pharma agrees US$11.75bn takeover of OrganonHealthcare / PharmaceuticalsIn review$11.8bn
  3. 323 SeptMerck KGaA → Bio-TechneBio-Techne shareholders back $11.3bn sale to Merck KGaAHealthcare / Life-science toolsIn review$11.3bn
  4. 422 JunAbbVie Inc. → Apogee Therapeutics, Inc.AbbVie agrees US$10.9bn deal for Apogee TherapeuticsHealthcare / BiotechCompleted$10.9bn
  5. 59 JunGSK plc → Nuvalent, Inc.GSK agrees US$10.6bn deal for NuvalentHealthcare / BiotechCompleted$10.6bn
  6. 66 JulVertex Pharmaceuticals Incorporated → Crinetics Pharmaceuticals, Inc.Vertex completes US$10bn takeover of CrineticsHealthcare / BiotechCompleted$10bn
  7. 717 FebDanaher Corporation → Masimo CorporationDanaher agrees US$9.9bn deal for MasimoHealthcare / Medical devicesCompleted$9.9bn
  8. 823 FebGilead Sciences, Inc. → Arcellx, Inc.Gilead agrees US$7.8bn deal for ArcellxHealthcare / BiotechCompleted$7.8bn
  9. 93 AugCurium → Lantheus HoldingsCurium agrees up to US$8bn deal for LantheusHealthcare / RadiopharmaceuticalsAgreed$7.5bn
  10. 1025 MarMerck & Co., Inc. → Terns Pharmaceuticals, Inc.Merck agrees US$6.7bn deal for Terns PharmaceuticalsHealthcare / BiotechCompleted$6.7bn
  11. 1131 MarEli Lilly and Company → Centessa Pharmaceuticals plcLilly agrees up to US$7.8bn deal for CentessaHealthcare / BiotechCompleted$6.3bn
  12. 126 OctCD&R and McKesson → Option Care HealthCD&R and McKesson agree $5.8bn buyout of Option Care HealthHealthcareAgreed$5.8bn
  13. 133 AugKKR → Integer Holdings CorporationKKR agrees US$5.7bn take-private of IntegerHealthcare / Medical device manufacturingAgreed$5.7bn
  14. 1431 MarBiogen Inc. → Apellis Pharmaceuticals, Inc.Biogen agrees US$5.6bn deal for ApellisHealthcare / BiotechCompleted$5.6bn
  15. 157 MayAngelini Pharma S.p.A. → Catalyst Pharmaceuticals, Inc.Angelini Pharma agrees US$4.1bn deal for Catalyst PharmaceuticalsHealthcare / Rare disease pharmaceuticalsCompleted$4.1bn
  16. 162 MarWelsh, Carson, Anderson & Stowe, Robert A. Ortenzio and Martin F. Jackson → Select Medical Holdings CorporationWCAS and Select Medical founders agree $3.9bn take-privateHealthcare / Rehabilitation and critical illness recoveryCompleted$3.9bn
  17. 1718 FebCovetrus, Inc. → MWI Animal Health (Cencora)Covetrus agrees US$3.5bn merger with Cencora's MWI Animal HealthHealthcare / Animal health distributionIn review$3.5bn
  18. 1820 AprEli Lilly and Company → Kelonia Therapeutics, Inc.Lilly agrees up-to-US$7bn deal for in vivo CAR-T developer KeloniaHealthcare / BiotechCompleted$3.3bn
  19. 197 AprGilead Sciences, Inc. → Tubulis GmbHGilead agrees up to US$5bn deal for TubulisHealthcare / BiotechCompleted$3.2bn
  20. 206 MarLone Star Funds (Lone Star Fund XII) → Lonza Capsules & Health Ingredients (60%)Lone Star agrees CHF2.3bn carve-out of Lonza's capsules armHealthcare / Capsules and nutrition ingredientsAgreed$3bn
  21. 216 AprNeurocrine Biosciences, Inc. → Soleno Therapeutics, Inc.Neurocrine agrees US$2.9bn takeover of Soleno TherapeuticsHealthcare / BiotechCompleted$2.9bn
  22. 2216 JulEli Lilly and Company → AtaiBeckley Inc.Lilly completes AtaiBeckley takeover worth up to US$3.8bnHealthcare / BiotechCompleted$2.8bn
  23. 2316 MarAmplifon S.p.A. → GN Hearing (GN Store Nord)Amplifon agrees €2.3bn deal for GN HearingHealthcare / Hearing aidsAgreed$2.6bn
  24. 246 MarServier → Day One Biopharmaceuticals, Inc.Servier agrees US$2.5bn deal for Day One BiopharmaceuticalsHealthcare / BiotechCompleted$2.5bn
  25. 259 FebEli Lilly and Company → Orna Therapeutics, Inc.Lilly agrees up to US$2.4bn deal for Orna TherapeuticsHealthcare / BiotechCompleted$2.4bn
  26. 2620 SeptTelix Pharmaceuticals → ITM Isotope Technologies MunichTelix agrees up to $2.35bn deal for Munich's ITMHealthcare / RadiopharmaAgreed$2.4bn
  27. 2725 AugMcKesson Corporation → Precision Medicine GroupMcKesson agrees US$2.25bn deal for Precision Medicine GroupHealthcare / Clinical research servicesAgreed$2.3bn
  28. 2827 Julargenx SE → Forte Biosciences, Inc.argenx completes US$2.2bn Forte Biosciences acquisitionHealthcare / BiotechCompleted$2.2bn
  29. 2920 JanGSK plc → RAPT Therapeutics, Inc.GSK agrees US$2.2bn deal for food allergy biotech RAPTHealthcare / BiotechCompleted$2.2bn
  30. 3012 OctSTERIS → Xodus MedicalSTERIS agrees US$2.1bn deal for Xodus MedicalHealthcare / Medical devicesAgreed$2.1bn
  31. 315 OctShionogi → IntraBioShionogi to buy IntraBio for about $2bnHealthcare / PharmaAgreed$2bn
  32. 323 MayUCB S.A. → Candid Therapeutics, Inc.UCB agrees deal worth up to US$2.2bn for Candid TherapeuticsHealthcare / BiotechCompleted$2bn
  33. 3320 MarNovartis AG → Pikavation Therapeutics (Synnovation Therapeutics)Novartis agrees US$2bn deal for Synnovation's PI3Kα unitHealthcare / BiotechCompleted$2bn
  34. 3429 AprChiesi Farmaceutici S.p.A. → KalVista Pharmaceuticals, Inc.Chiesi agrees US$1.9bn takeover of KalVistaHealthcare / BiotechCompleted$1.9bn
  35. 3516 OctSamsung Biologics → PolyPeptide Group AGSamsung Biologics' PolyPeptide offer succeeds with 87.9%Healthcare / Pharma CDMOAgreed$1.8bn
  36. 3623 MarGilead Sciences, Inc. → Ouro MedicinesGilead agrees US$1.7bn deal for Ouro MedicinesHealthcare / BiotechCompleted$1.7bn
  37. 378 OctViatris → Pacira BioSciencesViatris agrees $1.65bn cash deal for Pacira BioSciencesHealthcareAgreed$1.7bn
  38. 381 JunServier → Edgewise Therapeutics' muscular dystrophy business (sevasemten)Servier agrees up to US$2.65bn deal for Edgewise's sevasemtenHealthcare / BiotechCompleted$1.6bn
  39. 3914 OctGalderma → ZO Skin HealthGalderma agrees $1.5bn deal for Blackstone-backed ZO Skin HealthHealthcare / DermatologyAgreed$1.5bn
  40. 4022 JulRepligen Corporation → BioLife Solutions, Inc.Repligen completes US$1.5bn BioLife Solutions acquisitionHealthcare / Life science toolsCompleted$1.5bn
  41. 4120 JulTempus AI, Inc. → Personalis, Inc.Tempus agrees US$1.5bn deal for PersonalisHealthcare / DiagnosticsAgreed$1.5bn
  42. 4218 MayBoston Scientific Corporation → MiRus LLC (c.34% stake, with option on TAVR business)Boston Scientific invests US$1.5bn in MiRus with TAVR buyout optionHealthcare / Medical devicesCompleted$1.5bn
  43. 436 AugKKR → Medicover Hospitals IndiaKKR agrees €1.2bn deal for Medicover's Indian hospitalsHealthcare / HospitalsAgreed$1.4bn
  44. 449 OctToho Holdings → PHC HoldingsToho walks away from US$1.3bn PHC takeoverHealthcare / Medical devices and diagnosticsTerminated$1.3bn
  45. 4514 AprAmerican Industrial Partners → Avanos Medical, Inc.American Industrial Partners agrees US$1.27bn take-private of Avanos MedicalHealthcare / Medical devicesCompleted$1.3bn
  46. 468 JunIncyte Corporation → Vega Therapeutics, Inc. (subsidiary of Star Therapeutics)Incyte agrees up to US$2bn deal for Vega TherapeuticsHealthcare / BiotechCompleted$1.3bn
  47. 479 JunNovanta Inc. → Riverpoint MedicalNovanta agrees US$1.45bn deal for Riverpoint MedicalHealthcare / Medical devicesCompleted$1.2bn
  48. 487 JanEli Lilly and Company → Ventyx Biosciences, Inc.Lilly agrees US$1.2bn deal for Ventyx BiosciencesHealthcare / BiotechCompleted$1.2bn
  49. 4910 AugTeledyne Technologies → Varex ImagingTeledyne agrees US$1.1bn deal for Varex ImagingHealthcare / Medical imaging componentsAgreed$1.1bn
  50. 506 JulNovartis AG → Myricx BioNovartis buys Myricx Bio for up to US$1.5bnHealthcare / BiotechCompleted$1.1bn
  51. 5123 FebKinderhook Industries → Enhabit, Inc.Kinderhook agrees $1.1bn take-private of EnhabitHealthcare / Home health and hospiceCompleted$1.1bn
  52. 5227 AprAstorg (Astorg VIII) → Thermo Fisher Scientific microbiology business (Oxoid and Remel)Astorg buys Thermo Fisher's microbiology business for US$1.075bnHealthcare / DiagnosticsCompleted$1.1bn
  53. 538 JunJohnson & Johnson → Firefly Bio, Inc.Johnson & Johnson agrees US$1bn deal for Firefly BioHealthcare / BiotechCompleted$1bn
  54. 541 MayArchiMed → Esperion Therapeutics, Inc.ArchiMed agrees up to US$1.1bn take-private of EsperionHealthcare / PharmaceuticalsCompleted$1bn
  55. 559 MarAgilent Technologies Inc. → Biocare MedicalAgilent agrees US$950m deal for Biocare MedicalHealthcare / DiagnosticsCompleted$950m
  56. 5625 FebGSK plc → 35Pharma Inc.GSK agrees US$950m deal for 35PharmaHealthcare / BiotechCompleted$950m
  57. 5726 FebAsahi Kasei Corporation → AiCuris Anti-infective Cures AGAsahi Kasei agrees €780m deal for AiCurisHealthcare / BiotechCompleted$920m
  58. 5829 AprTeva Pharmaceutical Industries Ltd → Emalex BiosciencesTeva agrees up-to-US$900m deal for Tourette drug developer EmalexHealthcare / BiotechCompleted$900m
  59. 5925 JunH.B. Fuller Company → Advanced Medical Solutions Group plcH.B. Fuller agrees £659m takeover of Advanced Medical SolutionsHealthcare / Medical devicesAgreed$867m
  60. 606 JanAmgen Inc. → Dark Blue TherapeuticsAmgen buys UK protein-degrader biotech Dark Blue for up to $840mHealthcare / BiotechCompleted$840m
  61. 619 MarUniversal Health Services, Inc. → Talkspace, Inc.UHS agrees US$835m deal for TalkspaceHealthcare / Behavioural healthCompleted$835m
  62. 6210 AugJazz Pharmaceuticals plc → Actio BiosciencesJazz agrees US$820m deal for Actio BiosciencesHealthcare / BiotechAgreed$820m
  63. 637 MayRoche Holding AG → PathAI, Inc.Roche agrees deal worth up to US$1.05bn for PathAIHealthcare / Digital pathologyAgreed$750m
  64. 6422 AprAmneal Pharmaceuticals, Inc. → Kashiv BioSciences, LLCAmneal agrees up-to-US$1.1bn deal for biosimilars maker KashivHealthcare / BiosimilarsCompleted$750m
  65. 6527 AprLigand Pharmaceuticals Incorporated → XOMA Royalty CorporationLigand agrees US$739m takeover of XOMA RoyaltyHealthcare / Biopharma royaltiesCompleted$739m
  66. 6615 OctLabcorp Holdings Inc. → BioReference Health (select assets, from OPKO Health)Labcorp agrees to buy BioReference testing assets for up to US$872mHealthcare / DiagnosticsAgreed$722m
  67. 6727 MarOtsuka Pharmaceutical Co., Ltd. → Transcend Therapeutics, Inc.Otsuka agrees deal worth up to US$1.2bn for Transcend TherapeuticsHealthcare / BiotechCompleted$700m
  68. 6820 MayMedtronic plc → SPR Therapeutics, Inc.Medtronic agrees US$650m deal for SPR TherapeuticsHealthcare / Medical devicesCompleted$650m
  69. 6917 AprUCB SA → Neurona Therapeutics Inc.UCB agrees up-to-US$1.15bn deal for epilepsy cell therapy developer NeuronaHealthcare / BiotechCompleted$650m
  70. 7019 MarCollegium Pharmaceutical, Inc. → AZSTARYS (Corium Therapeutics)Collegium agrees US$650m deal for ADHD drug AZSTARYSHealthcare / PharmaceuticalsCompleted$650m
  71. 716 AugTarsus Pharmaceuticals → Alkeus PharmaceuticalsTarsus agrees US$450m deal for AlkeusHealthcare / BiotechCompleted$450m
  72. 7229 JunIpsen S.A. → Kartos Therapeutics, Inc.Ipsen agrees up to US$1.75bn deal for Kartos TherapeuticsHealthcare / BiotechCompleted$450m
  73. 7312 JanSmith & Nephew plc → Integrity Orthopaedics, Inc.Smith+Nephew agrees up to US$450m deal for Integrity OrthopaedicsHealthcare / Medical devicesCompleted$450m
  74. 746 MayKnox Lane → Cross Country Healthcare, Inc.Knox Lane takes Cross Country Healthcare private for US$437mHealthcare / StaffingCompleted$437m
  75. 7516 JunAltaris → Simulations Plus, Inc.Altaris to take Simulations Plus private for US$375mHealthcare / Drug development softwareAgreed$375m
  76. 7613 FebTakara Holdings Inc. → Takara Bio Inc.Takara Holdings bids ¥54bn to take Takara Bio privateHealthcare / Life science toolsCompleted$353m
  77. 7729 JulMiMedx Group, Inc. → Sanara MedTech Inc.MiMedx agrees US$350m deal for Sanara MedTechHealthcare / Medical devicesAgreed$350m
  78. 7813 AprRevenio Group Oyj → Visionix (LT International SAS)Revenio agrees €290m deal for VisionixHealthcare / Ophthalmic diagnosticsCompleted$339m
  79. 796 MayZakłady Farmaceutyczne Polpharma S.A. → Biofarm S.A.Polpharma agrees €270m takeover of Romania's BiofarmHealthcare / Generic pharmaceuticalsCompleted$320m
  80. 8016 AprCharterhouse Capital Partners (CCP Paw 2) → Animalcare Group plcCharterhouse agrees £235m take-private of veterinary group AnimalcareHealthcare / Veterinary pharmaceuticalsCompleted$320m
  81. 816 MayBayer AG → Perfuse Therapeutics, Inc.Bayer agrees deal worth up to US$2.45bn for Perfuse TherapeuticsHealthcare / BiotechCompleted$300m
  82. 822 MarGyre Therapeutics, Inc. → Cullgen Inc.Gyre agrees US$300m all-stock deal for CullgenHealthcare / BiotechCompleted$300m
  83. 836 AugiRhythm Holdings → VitalConnectiRhythm agrees US$288m deal for VitalConnectHealthcare / Medical devicesCompleted$288m
  84. 8428 JanSword Health → Kaia HealthSword Health buys Munich's Kaia Health for $285mHealthcare / Digital therapeuticsCompleted$285m
  85. 855 JunGNI Group → Ayumi Pharmaceutical HoldingsGNI Group buys Ayumi Pharmaceutical from Blackstone for ¥44.8bnHealthcare / PharmaceuticalsCompleted$280m
  86. 8618 AugBioMarin Pharmaceutical Inc. → Alesta TherapeuticsBioMarin agrees US$275m upfront deal for Alesta TherapeuticsHealthcare / BiotechCompleted$275m
  87. 8726 MayOlympus Corporation → BioProtect Ltd.Olympus pays US$270m for Israel's BioProtectHealthcare / Medical devicesCompleted$270m
  88. 8814 AprEverstone Capital → Apothecon Group (Apothecon Pharmaceuticals and Navinta)Everstone invests US$270m in Indian generics maker ApotheconHealthcare / Generic pharmaceuticalsAgreed$270m
  89. 892 MarRadNet, Inc. → Gleamer SASRadNet buys Gleamer for up to €230mHealthcare / Radiology AICompleted$269m
  90. 9013 OctAgilent Technologies → ProsciaAgilent agrees to buy digital pathology firm Proscia for up to US$270mHealthcare / Digital pathology softwareAgreed$240m
  91. 915 AugNippon Investment Company (NIC Fund, via SK-03) → CE Holdings Co., Ltd.NIC fund launches ¥26.2bn take-private of CE HoldingsHealthcare / Medical information systemsAgreed$170m
  92. 9216 FebOptima Health plc → PAM Healthcare LimitedOptima Health agrees £100m deal for PAM HealthcareHealthcare / Occupational healthCompleted$136m
  93. 937 MayArtivion, Inc. → Endospan Ltd.Artivion exercises option to buy Endospan after NEXUS approvalHealthcare / Medical devicesCompleted$135m
  94. 9418 FebOrganigram Global Inc. → Sanity Group GmbHOrganigram agrees €113m deal for Sanity GroupHealthcare / Medical cannabisCompleted$134m
  95. 9513 FebAlkem Laboratories Ltd (Alkem MedTech) → Occlutech Holding AG (majority stake)Alkem buys majority of Swiss heart-implant maker Occlutech for €99.4mHealthcare / Medical devicesCompleted$118m
  96. 9615 OctMankind Pharma Limited (via Mankind Pharma (Netherlands) B.V.) → Armed Cell Therapeutics B.V. (ACTx) – 70% stakeMankind Pharma takes 70% of Belgian CAR-T developer ACTx for €48mHealthcare / BiotechAgreed$56m
  97. 9718 FebDr. Reddy's Laboratories Ltd → Progynova and Cyclo-Progynova India brands (Mercury Pharma Group)Dr. Reddy's enters hormone therapy with $32m Progynova purchaseHealthcare / PharmaceuticalsCompleted$32m
  98. 9817 AugManipal Health Enterprises Limited → Kinder Women's Hospital and Fertility Centre, Bengaluru (business of Kindorama Healthcare)Manipal Health agrees INR 1.3bn deal for Kinder Women's HospitalHealthcare / HospitalsAgreed$14m
  99. 9917 MarStrides Pharma Science Limited (via Strides Pharma International AG) → Sandoz branded generics portfolio in Sub-Saharan AfricaStrides buys Sandoz branded generics in Sub-Saharan AfricaHealthcare / Generic pharmaceuticalsAgreed$12m
  100. 10016 OctParkview Health → Ovation HealthcareParkview Health agrees to acquire Ovation HealthcareHealthcare / Hospital servicesAgreedUndisclosed
  101. 1019 OctMidea Group → EsaoteMidea completes takeover of Italian imaging group EsaoteHealthcare / Medical imagingCompletedUndisclosed
  102. 1027 OctRespighi BidCo (CVC, GBL) → RecordatiCVC and GBL raise Recordati bid to final €53 a shareHealthcareIn reviewUndisclosed
  103. 1031 OctFresenius → mAbxience (remaining 45%)Fresenius takes full control of mAbxience for up to EUR750mHealthcare / BiosimilarsCompletedUndisclosed
  104. 10417 SeptEB Development → Eurobio ScientificEurobio Scientific's owner moves to delist at €25.30 a shareHealthcareAnnouncedUndisclosed
  105. 10531 AugEli Lilly and Company → Merida BiosciencesLilly agrees up to US$2.9bn deal for Merida BiosciencesHealthcare / BiotechAgreedUndisclosed
  106. 10618 AugMedbase Group → Ardentis (majority stake)Medbase takes control of ArdentisHealthcare / Dental clinicsCompletedUndisclosed
  107. 10711 AugAlfasigma S.p.A. → Nordic Group B.V. (Nordic Pharma)Alfasigma agrees to buy Nordic PharmaHealthcare / Specialty pharmaAgreedUndisclosed
  108. 10820 JulDubai Investments PJSC → Clemenceau Medical Center Dubai (80%)Dubai Investments takes full ownership of Clemenceau Medical Center DubaiHealthcare / HospitalsCompletedUndisclosed
  109. 10913 JulWarburg Pincus-led investor group → PANTHERx RareWarburg Pincus-led group agrees to buy control of PANTHERx RareHealthcare / Specialty pharmacyAgreedUndisclosed
  110. 1107 JulEQT (EQT X) → Corza Biosurgery (TachoSil)EQT agrees to buy TachoSil business from Corza MedicalHealthcare / Surgical biologicsAgreedUndisclosed
  111. 11125 JunAdvent International → Japan Wellbeing Corp.Advent buys Japan Wellbeing from MBK in first Japan dealHealthcare / Elderly careAgreedUndisclosed
  112. 11217 JunBiogen Inc. → RayThera Inc.Biogen agrees up to US$1bn deal for RayTheraHealthcare / BiotechCompletedUndisclosed
  113. 11310 JunAster DM Healthcare (GCC) → ProCare HospitalAster DM Healthcare takes control of Saudi Arabia's ProCare HospitalHealthcare / HospitalsCompletedUndisclosed
  114. 11426 MayEli Lilly and Company → Curevo, Inc.Lilly agrees deal worth up to US$1.5bn for shingles vaccine maker CurevoHealthcare / VaccinesAgreedUndisclosed
  115. 11526 MayEli Lilly and Company → LimmaTech Biologics AGLilly agrees up-to-US$780m deal for Swiss vaccine maker LimmaTechHealthcare / VaccinesAgreedUndisclosed
  116. 11626 MayStonepeak-led consortium (with Axight Capital) → Estia HealthStonepeak consortium agrees to buy Estia Health from BainHealthcare / Aged careAgreedUndisclosed
  117. 11718 MayMehiläinen Group → Aleris GroupMehiläinen agrees to buy Aleris from TritonHealthcare / Specialist care providersAgreedUndisclosed
  118. 11827 AprEli Lilly and Company → Ajax Therapeutics, Inc.Lilly agrees up-to-US$2.3bn deal for JAK2 specialist AjaxHealthcare / BiotechCompletedUndisclosed
  119. 11924 AprJohnson & Johnson → Atraverse Medical, Inc.J&J agrees to buy left-heart access specialist Atraverse MedicalHealthcare / Medical devicesCompletedUndisclosed
  120. 12023 AprInventurus Knowledge Solutions (IKS Health) → TruBridge, Inc.IKS Health agrees to buy rural hospital software provider TruBridgeHealthcare / Health ITCompletedUndisclosed
  121. 12127 MarNovartis AG → Excellergy, Inc.Novartis agrees deal worth up to US$2bn for ExcellergyHealthcare / BiotechCompletedUndisclosed
  122. 12223 JanNissha Co., Ltd. → USM Healthcare Medical Devices Factory JSCNissha agrees to buy control of Vietnam's USM HealthcareHealthcare / Medical devicesCompletedUndisclosed
  123. 12314 JanEQT X fund → Oxford Biomedica plcEQT abandons pursuit of Oxford BiomedicaHealthcare / Cell and gene therapy manufacturingTerminatedUndisclosed
  124. 12412 JanBoston Scientific Corporation → Valencia Technologies CorporationBoston Scientific agrees to buy eCoin maker Valencia TechnologiesHealthcare / Medical devicesCompletedUndisclosed